Drug Tragedies: The Dark Epoch of Clinical Prosecutions That Made Manhood Mysterious Fatalities

Hindustan Abdul Ahad*, Chinthaginjala Haranath, Akkinepalli Anoohya, Janaki Tejaswini and Kuruva Veeresh
Additional contact information
Hindustan Abdul Ahad*: Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, Ananthapuramu, Andhra Pradesh, India
Chinthaginjala Haranath: Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, Ananthapuramu, Andhra Pradesh, India
Akkinepalli Anoohya: Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, Ananthapuramu, Andhra Pradesh, India
Janaki Tejaswini: Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, Ananthapuramu, Andhra Pradesh, India
Kuruva Veeresh: Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, Ananthapuramu, Andhra Pradesh, India

Noble International Journal of Scientific Research, 2021, vol. 5, issue 2, 10-15

Abstract: Today, the highest importance is given to the patient’s safety and ethics during the clinical trials. The regulatory authorities take each and every aspect into consideration to protect the safety, rights and consent of the subjects during the phases of clinical trials. Besides the applications like IND, NDA further strengthen these above parameters. However, all these safety measures are a result of our previous experiences in history such as Thalidomide tragedy, Sulphanilamide disaster, Nazi’s experiments, Tuskegee syphilis studies. All these disasters are due to unethical behavior, lack of knowledge on safety, no keen idea on pharmacovigilance, no proper data storage, inexperience etc., which led to many disasters resulting in the deaths of many innocent lives and some permanent damage to the persons consuming these drugs either by force or voluntarily. This article mainly focuses on the drug tragedies and drugs introvert from the market, due to the lack of knowledge on clinical trials.

Keywords: Clinical Trials; Drug Tragedies; Regulatory Authorities; Safety; Efficacy (search for similar items in EconPapers)
Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.napublisher.org/pdf-files/NIJSR-5(2)-10-15.pdf (application/pdf)
https://www.napublisher.org/?ic=journal&journal=9&month=06-2021&issue=2&volume=5 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nap:nijsrr:2021:p:10-15

Access Statistics for this article

Noble International Journal of Scientific Research is currently edited by Dr. Mohammad Arif Kamal

More articles in Noble International Journal of Scientific Research from Noble Academic Publsiher Flat 290 B N Block Model Town, Lahore, Punjab, Pakistan.
Bibliographic data for series maintained by Managing Editor ( this e-mail address is bad, please contact ).